ATE80306T1 - Mittel zur absorptionsverbesserung von proteinen. - Google Patents

Mittel zur absorptionsverbesserung von proteinen.

Info

Publication number: ATE80306T1
Authority: AT; Austria
Prior art keywords: proteins; improving absorption; absorption; improving; hydroxylamine
Prior art date: 1985-03-06

Application number

AT86902132T

Other languages

English (en)

Inventor

Stanley Jay Sarnoff

Burton E Sobel

Original Assignee

Survival Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-06

Filing date

1986-03-06

Publication date

1992-09-15

1985-03-06 Priority claimed from US06/708,845 external-priority patent/US4661469A/en

1985-10-01 Priority claimed from US06/782,441 external-priority patent/US4772585A/en

1986-03-06 Application filed by Survival Technology filed Critical Survival Technology

1992-09-15 Application granted granted Critical

1992-09-15 Publication of ATE80306T1 publication Critical patent/ATE80306T1/de

Links

238000010521 absorption reaction Methods 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
230000007721 medicinal effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Zoology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT86902132T 1985-03-06 1986-03-06 Mittel zur absorptionsverbesserung von proteinen. ATE80306T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US06/708,845 US4661469A (en)	1984-08-08	1985-03-06	t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A	1985-03-27	1985-03-27
US06/782,441 US4772585A (en)	1984-08-08	1985-10-01	Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en)	1985-03-06	1986-03-06	Protein absorption enhancing agents
EP86902132A EP0214281B1 (de)	1985-03-06	1986-03-06	Mittel zur absorptionsverbesserung von proteinen

Publications (1)

Publication Number	Publication Date
ATE80306T1 true ATE80306T1 (de)	1992-09-15

Family

ID=27418848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86902132T ATE80306T1 (de)	1985-03-06	1986-03-06	Mittel zur absorptionsverbesserung von proteinen.

Country Status (9)

Country	Link
EP (1)	EP0214281B1 (de)
AT (1)	ATE80306T1 (de)
AU (1)	AU593794B2 (de)
DE (1)	DE3686684T2 (de)
DK (1)	DK528386D0 (de)
FI (1)	FI864480A0 (de)
HU (1)	HUT41632A (de)
NO (1)	NO864382D0 (de)
WO (1)	WO1986005096A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839170A (en) *	1985-10-01	1989-06-13	Survival Technology, Inc.	Protein absorption enhancing agents
DE3544663A1 (de) *	1985-12-13	1987-06-19	Schering Ag	Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE58574B1 (en) *	1985-04-22	1993-10-06	Genentech Inc	Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants
AU569429B2 (en) *	1985-05-28	1988-01-28	Wellcome Foundation Limited, The	Aqueous acidic tissue plasminogen activator parenternal formulation

1986
- 1986-03-06 WO PCT/US1986/000475 patent/WO1986005096A1/en not_active Ceased
- 1986-03-06 HU HU863035A patent/HUT41632A/hu unknown
- 1986-03-06 FI FI864480A patent/FI864480A0/fi not_active Application Discontinuation
- 1986-03-06 AU AU55811/86A patent/AU593794B2/en not_active Ceased
- 1986-03-06 EP EP86902132A patent/EP0214281B1/de not_active Expired - Lifetime
- 1986-03-06 AT AT86902132T patent/ATE80306T1/de not_active IP Right Cessation
- 1986-03-06 DE DE8686902132T patent/DE3686684T2/de not_active Expired - Fee Related
- 1986-11-03 NO NO864382A patent/NO864382D0/no unknown
- 1986-11-05 DK DK528386A patent/DK528386D0/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU593794B2 (en)	1990-02-22
HUT41632A (en)	1987-05-28
DE3686684T2 (de)	1993-01-28
EP0214281A4 (de)	1989-03-16
EP0214281A1 (de)	1987-03-18
AU5581186A (en)	1986-09-24
EP0214281B1 (de)	1992-09-09
WO1986005096A1 (en)	1986-09-12
NO864382D0 (no)	1986-11-03
NO864382L (no)	1986-03-11
FI864480L (fi)	1986-11-04
DK528386A (da)	1986-11-05
FI864480A7 (fi)	1986-11-04
DE3686684D1 (de)	1992-10-15
FI864480A0 (fi)	1986-11-04
DK528386D0 (da)	1986-11-05

Similar Documents

Publication	Publication Date	Title
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3685625D1 (de)	1992-07-16	Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
DE3687741D1 (de)	1993-03-25	Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
DE3682457D1 (de)	1991-12-19	Geraet zur verabreichung von medikamenten an patienten.
DK317288A (da)	1988-12-13	Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DK165199C (da)	1993-03-01	Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
ATE69548T1 (de)	1991-12-15	Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
IT1067019B (it)	1985-03-12	Metodo e disposizione per misurare la concentrazione di composti di basso peso molecolare in mezzi complessi in particolare nel trattamento medicale
NO883834L (no)	1989-02-28	Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
FI863626A7 (fi)	1986-09-09	DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
FI896261A7 (fi)	1989-12-22	Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
ATE80306T1 (de)	1992-09-15	Mittel zur absorptionsverbesserung von proteinen.
DE69523055D1 (de)	2001-11-08	T-zellen stimulierendes protein von pestivirus
DK325289D0 (da)	1989-06-29	Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
FI92716C (fi)	1994-12-27	Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
AU4721185A (en)	1986-03-07	Protein absorption enhancing agents
FI885025A0 (fi)	1988-11-01	Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ATE79550T1 (de)	1992-09-15	Die proteinabsorption verbessernde stoffe.
ATE126437T1 (de)	1995-09-15	Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
NO864742D0 (no)	1986-11-26	Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.
ATE105570T1 (de)	1994-05-15	Modifizierte menschliche anti-rh(d)-antikoerper.
DK381787D0 (da)	1987-07-21	Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
IT8421612A0 (it)	1984-06-26	Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
IT207181Z2 (it)	1987-12-14	Flaconcino con cannula sigillata monouso.

Legal Events

Date	Code	Title	Description
1993-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties